{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:52:11Z","timestamp":1774533131700,"version":"3.50.1"},"reference-count":30,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2019,1,31]]},"DOI":"10.1536\/ihj.18-012","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T17:36:51Z","timestamp":1543945011000},"page":"115-120","source":"Crossref","is-referenced-by-count":15,"title":["Natriuretic Peptide Processing in Patients with and Without Left Ventricular Dysfunction"],"prefix":"10.1536","volume":"60","author":[{"given":"Sofie","family":"Verstreken","sequence":"first","affiliation":[{"name":"Cardiovascular Center, Onze Lieve Vrouw Ziekenhuis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leen","family":"Delrue","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Onze Lieve Vrouw Ziekenhuis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Goethals","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Onze Lieve Vrouw Ziekenhuis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozef","family":"Bartunek","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Onze Lieve Vrouw Ziekenhuis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Vanderheyden","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Onze Lieve Vrouw Ziekenhuis"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316-22.","DOI":"10.1016\/S0140-6736(03)13976-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail 2004; 6: 261-8.","DOI":"10.1016\/j.ejheart.2004.01.004"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Heublein DM, Heublein DM, Huntley BK, <i>et al<\/i>. Immunoreactivity and guanosine 3 &quot;,5-&quot; cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide. Hypertension 2007; 49: 1114-9.","DOI":"10.1161\/HYPERTENSIONAHA.106.081083"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Liang F, O&apos;Rear J, Schellenberger U, <i>et al<\/i>. Evidence for functional heterogeneity of circulating B-Type natriuretic peptide. J Am Coll Cardiol 2007; 49: 1071-8.","DOI":"10.1016\/j.jacc.2006.10.063"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jourdain P, Jondeau G, Funck F, <i>et al<\/i>. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure. J Am Coll Cardiol 2007; 49: 1733-9.","DOI":"10.1016\/j.jacc.2006.10.081"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Maisel A, Mueller C, Adams Jr K, <i>et al<\/i>. State of the art: Using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008; 10: 824-39.","DOI":"10.1016\/j.ejheart.2008.07.014"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jin M, Wei S, Gao R, <i>et al<\/i>. Predictors of Long-Term Mortality in Patients With Acute Heart Failure. Int Heart J 2017; 58: 409-15.","DOI":"10.1536\/ihj.16-219"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Tsutamoto T, Wada A, Maeda K, <i>et al<\/i>. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-16.","DOI":"10.1161\/01.CIR.96.2.509"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tsutamoto T, Kanamori T, Wada A, Kinoshita M. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure. J Am Coll Cardiol 1992; 20: 541-6.","DOI":"10.1016\/0735-1097(92)90005-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nakajima K, Onishi K, Dohi K, <i>et al<\/i>. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels. Int J Cardiol 2005; 104: 332-7.","DOI":"10.1016\/j.ijcard.2004.12.020"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Vanderheyden M, Vrints C, Verstreken S, Bartunek J, Beunk J, Goethals M. B-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications. Biomark Med 2010; 4: 315-20.","DOI":"10.2217\/bmm.10.5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lam CS, Burnett JC Jr, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. J Am Coll Cardiol 2007; 49: 1193-202.","DOI":"10.1016\/j.jacc.2006.12.024"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Waldo SW, Beede J, Isakson S, <i>et al<\/i>. Pro-B-type natriuretic peptide levels in acute decompensated heart failure. J Am Coll Cardiol 2008; 51: 1874-82.","DOI":"10.1016\/j.jacc.2007.12.051"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sykes E, Sykes E, Karcher RE, <i>et al<\/i>. Analytical relationships among Biosite, Bayer, and Roche methods for BNP and NT-proBNP. Am J Clin Pathol 2005; 123: 584-90.","DOI":"10.1309\/F86FVEFDGX06DTUV"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ishida J, Suzuki T, Aizawa K, Sawaki D, Nagai R. Comparison of analytical performance of two single-step measurement devices of B-type natriuretic Peptide. Int Heart J 2012; 53: 320-3.","DOI":"10.1536\/ihj.53.320"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Giuliani I. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 2006; 52: 1054-61.","DOI":"10.1373\/clinchem.2005.061770"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Heymes C, Vanderheyden M, Bronzwaer JG, Shah AM, Paulus WJ. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation 1999; 99: 3009-16.","DOI":"10.1161\/01.CIR.99.23.3009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Vanderheyden M, Mullens W, Delrue L, <i>et al<\/i>. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. J Am Coll Cardiol 2008; 51: 129-36.","DOI":"10.1016\/j.jacc.2007.07.087"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lowes BD, Lowes BD, Minobe W, <i>et al<\/i>. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 1997; 100: 2315-24.","DOI":"10.1172\/JCI119770"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yu Z, Zhang H, Yu M, Ye Q. Analysis of gene expression during the development of congestive heart failure after myocardial infarction in rat models. Int Heart J 2015; 56: 444-9.","DOI":"10.1536\/ihj.14-422"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Dries DL, Ky B, Wu AH, Rame JE, Putt ME, Cappola TP. Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure. Circ Heart Fail 2010; 3: 220-7.","DOI":"10.1161\/CIRCHEARTFAILURE.109.903153"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Xu-Cai YO, Wu Q. Molecular forms of natriuretic peptides in heart failure and their implications. Heart 2010; 96: 419-24.","DOI":"10.1136\/hrt.2008.164145"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hawkridge AM, Heublein DM, Bergen HR, Cataliotti A, Burnett JC, Muddiman DC. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci USA 2005; 102: 17442-7.","DOI":"10.1073\/pnas.0508782102"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wu Q. The serine protease corin in cardiovascular biology and disease. Front Biosci 2007; 12: 4179-90.","DOI":"10.2741\/2379"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Dries DL, Victor RG, Rame JE, <i>et al<\/i>. Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation 2005; 112: 2403-10.","DOI":"10.1161\/CIRCULATIONAHA.105.568881"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Chan JC, Knudson O, Wu F, Morser J, Dole WP, Wu Q. Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. Proc Natl Acad Sci USA 2005; 102: 785-90.","DOI":"10.1073\/pnas.0407234102"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Dong N, Chen S, Yang J, <i>et al<\/i>. Plasma soluble corin in patients with heart failure. Circ Heart Fail 2010; 3: 207-11.","DOI":"10.1161\/CIRCHEARTFAILURE.109.903849"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Tran KL, Lu X, Lei M, Feng Q, Wu Q. Upregulation of corin gene expression in hypertrophic cardiomyocytes and failing myocardium. Am J Physiol Heart Circ Physiol 2004; 287: H1625-31.","DOI":"10.1152\/ajpheart.00298.2004"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Chen S, Sen S, Young D, Wang W, Moravec CS, Wu Q. Protease corin expression and activity in failing hearts. Am J Physiol Heart Circ Physiol 2010; 299: H1687-92.","DOI":"10.1152\/ajpheart.00399.2010"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ibebuogu UN, Gladysheva IP, Houng AK, Reed GL. Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide. Circ Heart Fail 2011; 4: 114-20.","DOI":"10.1161\/CIRCHEARTFAILURE.109.895581"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/1\/60_18-012\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T21:46:17Z","timestamp":1548539177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/1\/60_18-012\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.18-012","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]}}}